Baird Financial Group, Inc. Avid Bioservices, Inc. Transaction History

Baird Financial Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$15.33 - $20.36 $22,995 - $30,540	1,500 Added 1.82%	83,737 $1.6 Million
Q2 2022 Aug 08, 2022	BUY	$11.63 - $21.55 $51,520 - $95,466	4,430 Added 5.69%	82,237 $1.26 Million
Q1 2022 May 13, 2022	BUY	$16.63 - $27.73 $125,473 - $209,222	7,545 Added 10.74%	77,807 $1.59 Million
Q4 2021 Feb 09, 2022	BUY	$20.7 - $34.18 $158,230 - $261,271	7,644 Added 12.21%	70,262 $2.05 Million
Q3 2021 Nov 12, 2021	BUY	$19.05 - $28.32 $235,686 - $350,375	12,372 Added 24.62%	62,618 $1.35 Million
Q2 2021 Aug 11, 2021	BUY	$18.93 - $25.65 $290,253 - $393,291	15,333 Added 43.92%	50,246 $1.29 Million
Q1 2021 May 13, 2021	BUY	$11.86 - $21.77 $414,068 - $760,056	34,913 New	34,913 $636,000

184

67.8M

89.9K

118K

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $770M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Baird Financial Group, Inc. with notifications on news.